Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma Progression”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00171925
What this trial is testing

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Who this might be right for
Multiple Myeloma Stage I
Novartis Pharmaceuticals 143
Testing effectiveness (Phase 2)Active Not RecruitingNCT03004287
What this trial is testing

2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy

Who this might be right for
Multiple Myeloma
University of Arkansas 50
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Testing effectiveness (Phase 2)Study completedNCT01008462
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17p+18 more
Fred Hutchinson Cancer Center 16
Large-scale testing (Phase 3)Ended earlyNCT05675319
What this trial is testing

Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 28
Testing effectiveness (Phase 2)Study completedNCT00619684
What this trial is testing

Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell Transplant

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Center 18
Early research (Phase 1)WithdrawnNCT06411301
What this trial is testing

A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors

Who this might be right for
Multiple Myeloma, RefractoryMultiple Myeloma in RelapseMultiple Myeloma Progression
Jules Bordet Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT04850846
What this trial is testing

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 60
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Not applicableLooking for participantsNCT06690593
What this trial is testing

Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Intestinal FloraMultiple Myeloma+1 more
Zhujiang Hospital 2,990
Large-scale testing (Phase 3)Study completedNCT01621672
What this trial is testing

UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 42
Early research (Phase 1)Ended earlyNCT05153330
What this trial is testing

Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Mixed-Phenotype Leukemia+12 more
Biomea Fusion Inc. 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07029776
What this trial is testing

MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
University of Arkansas 50
Testing effectiveness (Phase 2)Ended earlyNCT03411031
What this trial is testing

Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 18
Not applicableEnded earlyNCT01794572
What this trial is testing

Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse

Who this might be right for
Multiple Myeloma in Relapse
Institut Cancerologie de l'Ouest 13
Not applicableStudy completedNCT02164955
What this trial is testing

A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.

Who this might be right for
Multiple Myeloma
Celgene 775
Early research (Phase 1)UnknownNCT03706547
What this trial is testing

Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma Progression
Peng Liu 20
Large-scale testing (Phase 3)Study completedNCT01109004
What this trial is testing

Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 758
Large-scale testing (Phase 3)Study completedNCT01191060
What this trial is testing

Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years

Who this might be right for
Myeloma
University Hospital, Toulouse 700
Large-scale testing (Phase 3)Study completedNCT00378222
What this trial is testing

Autologous Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Bologna 324
Next Page